PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New protein linked to early-onset dementia identified

Researchers have established a first potential therapeutic target for a type of early-onset dementia.

2023-12-06
(Press-News.org) Most neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these diseases, researchers have identified the proteins that aggregate, allowing them to target these proteins for diagnostic tests and treatments.

But, in around 10% of cases of frontotemporal dementia, scientists had yet to identify the rogue protein. Now, scientists have pinpointed aggregated structures of the protein TAF15 in these cases.

Frontotemporal dementia results from the degeneration of the frontal and temporal lobes of the brain, which control emotions, personality and behaviour, as well speech and understanding of words. It tends to start at a younger age than Alzheimer's disease, often being diagnosed in people aged 45 to 65, although it can also affect younger or older people.

In a paper published today in the journal Nature, research led by scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology, in Cambridge, UK, has identified aggregated structures of a protein that could provide a target for the future development of diagnostic tests and treatments.

Dr Benjamin Ryskeldi-Falcon, who led the study at the MRC Laboratory of Molecular Biology, said: “This discovery transforms our understanding of the molecular basis of frontotemporal dementia. It is a rare finding of a new member of the small group of proteins known to aggregate in neurodegenerative disease.

“Now that we have identified the key protein and its structure, we can start to target it for the diagnosis and therapy of this type of frontotemporal dementia, similar to strategies already in the pipeline for targeting the aggregates of amyloid-beta and tau proteins that characterise Alzheimer's disease.” 

The scientists used cutting-edge cryo-electron microscopy (cryo-EM) to study protein aggregates from the brains of four people who had this type of frontotemporal dementia at atomic resolution. The donated brains were identified by Tammaryn Lashley at the University College London Queen Square Institute of Neurology and Bernardino Ghetti at the Indiana University School of Medicine.

In this type of dementia, scientists had long thought that a protein called FUS aggregated, based on similarities with other neurodegenerative diseases.

Using cryo-EM, the researchers at the MRC Laboratory of Molecular Biology were able to identify that the protein aggregates from each brain had the same atomic structure. Surprisingly, the protein was not FUS – it was another protein called TAF15.

Dr Stephan Tetter, also from the MRC Laboratory of Molecular Biology, who is first author on the paper, said: “This is an unexpected result because, before this study, TAF15 was not known to form amyloid filaments in neurodegenerative diseases and no structures of the protein existed. Cryo-EM is transforming our understanding of the molecular pathology of dementia and neurodegenerative diseases more broadly by giving us insights that were beyond the capabilities of previous technologies.”

Dr Ryskeldi-Falcon added: “The technical challenge of performing cryo-EM meant that we were only able to look at the brains of four individuals. However, now that we know the key protein and its structure, we have the potential to develop tools to screen for these abnormal protein aggregates in hundreds of patient samples to test how widespread they are.”

Frontotemporal dementia and motor neuron disease

Some people who have frontotemporal dementia also have motor neuron disease, a condition in which individuals progressively lose control over their muscles. In this study, two of the individuals who donated their brains had signs of both diseases. For these individuals, the researchers identified the same aggregated structure of TAF15 in brain regions associated with motor neuron disease.

Dr Ryskeldi-Falcon said: “The presence of the same TAF15 aggregates in two individuals who had frontotemporal dementia and signs of motor neuron disease raises the possibility that TAF15 may contribute to both diseases. We are now studying whether aberrant aggregated TAF15 is present in people who have motor neurone disease in the absence of frontotemporal dementia.”

This study was funded by the Medical Research Council, Alzheimer’s Research UK, the US National Institutes of Health, the Alzheimer’s Society, the Association for Frontotemporal Degeneration, the Swiss National Science Foundation, and the Leverhulme Trust.

Dr Charlotte Durkin, Head of the Medical Research Council’s Molecular and Cellular Medicine Board, said:

“Decades of world-leading research at the MRC Laboratory of Molecular Biology brought the breakthrough of cryoelectron microscopy - gaining Dr Richard Henderson a Nobel Prize in 2017. This latest study identifying the protein linked to a type of frontotemporal dementia continues the MRC LMB’s success in elucidating dementia-related protein structures by cryoEM, which includes the first structure for the key dementia protein tau. Knowing the identity and basic structure of these filaments in this rare form of early-onset dementia is vital to developing early diagnostic tests and drugs to combat their formation.”

ENDS

Notes to editors

To speak to the study authors or for a copy of the paper, please contact: the UKRI press office: press@ukri.org; 01793 298902

High resolution photos and images associated with the study can be downloaded from: https://cloud.mrc-lmb.cam.ac.uk/s/3C7LqTH5XAMfb6j.

‘TAF15 amyloid filaments in frontotemporal lobar degeneration’, by S. Tetter et al. will be published in Nature. Link once online: https://www.nature.com/articles/s41586-023-06801-2

For awareness: motor neuron disease is also commonly referred to using the terms amyotrophic lateral sclerosis (ALS) and is known as Lou Gehrig's disease in the US. More about proteins involved in dementia and cryo-EM at the MRC LMB: https://www2.mrc-lmb.cam.ac.uk/news-and-events/public-engagement/lmb-science-stories/tau-and-alzheimers/    https://www2.mrc-lmb.cam.ac.uk/news-and-events/public-engagement/lmb-science-stories/cryo-electron-microscopy/ More about frontotemporal dementia: https://www.alzheimersresearchuk.org/dementia-information/types-of-dementia/frontotemporal-dementia/ About the MRC Laboratory of Molecular Biology

The Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) is one of the world's leading research institutes.  Discoveries and inventions developed at the LMB, for example DNA sequencing and methods to determine the structure of proteins, have revolutionised all areas of biology.  Its scientists work to advance understanding of biological processes at the molecular level.  This information will help us to understand the workings of complex systems, such as the immune system and the brain, and solve key problems in human health. http://www2.mrc-lmb.cam.ac.uk/

The Medical Research Council is at the forefront of scientific discovery to improve human health. Founded in 1913 to tackle tuberculosis, the MRC now invests taxpayers’ money in some of the best medical research in the world across every area of health. Thirty-three MRC-funded researchers have won Nobel prizes in a wide range of disciplines, and MRC scientists have been behind such diverse discoveries as vitamins, the structure of DNA and the link between smoking and cancer, as well as achievements such as pioneering the use of randomised controlled trials, the invention of MRI scanning, and the development of a group of antibodies used in the making of some of the most successful drugs ever developed. Today, MRC-funded scientists tackle some of the greatest health problems facing humanity in the 21st century, from the rising tide of chronic diseases associated with ageing to the threats posed by rapidly mutating micro-organisms. The Medical Research Council is part of UK Research and Innovation. https://mrc.ukri.org/

UK Research and Innovation works in partnership with universities, research organisations, businesses, charities, and government to create the best possible environment for research and innovation to flourish. We aim to maximise the contribution of each of our component parts, working individually and collectively. We work with our many partners to benefit everyone through knowledge, talent and ideas.

Operating across the whole of the UK with a combined budget of more than £7 billion, UK Research and Innovation brings together the seven research councils, Innovate UK and Research England. www.ukri.org

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Stellar winds regulate growth of galaxies

Stellar winds regulate growth of galaxies
2023-12-06
Galactic winds enable the exchange of matter between galaxies and their surroundings. In this way, they limit the growth of galaxies, that is, their star formation rate. Although this had already been observed in the local universe, an international research team led by a CNRS scientist1 has just revealed—using MUSE,2 an instrument integrated into the European Southern Observatory’s (ESO) Very Large Telescope—the existence of the phenomenon in galaxies which are more than 7 billion years old and actively forming stars, the category to which most galaxies belong. The team’s ...

Study finds individuals with acne face social and professional stigma

2023-12-06
Brigham researchers found that individuals with darker skin tones and more severe acne were likely to face greater stigma  Researchers note the importance of treating acne as a medical problem and ensuring access to treatment    A new study highlights how stigmatizing attitudes about individuals with acne may influence social and professional perceptions. Led by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, the study ...

A type of allergy medicine might help treat lung cancer, research suggests

A type of allergy medicine might help treat lung cancer, research suggests
2023-12-06
New York, NY (December 6, 2023)—Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).   And in an early parallel study in humans, combining immunotherapy with dupilumab—an Interleukin-4 (IL-4) receptor-blocking antibody widely used for treating allergies and asthma—boosted patients' immune systems, with one out of the six experiencing significant tumor reduction.   The findings were ...

Economic burden of health conditions associated with adverse childhood experiences among US adults

2023-12-06
About The Study: In this cross-sectional analysis of the U.S. adult population, 63% of adults had adverse childhood experiences (ACEs). The economic burden of ACE-related health conditions was substantial. The findings suggest that measuring the economic burden of ACEs can support decision-making about investing in strategies to improve population health.  Authors: Cora Peterson, Ph.D., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.   To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2023.46323) Editor’s Note: Please ...

Evaluation of stigma toward individuals with acne

2023-12-06
About The Study: This survey study with 1,357 respondents demonstrates that stigmatizing attitudes toward patients with acne existed across a variety of social and professional scenarios, with severe acne and acne in darker skin tone being associated with a greater degree of stigma. These findings highlight the need to identify approaches to reduce stigmatizing attitudes in the community and for adequate access to care, which might prevent negative downstream effects related to these stigmatizing attitudes. Authors: John ...

COVID-19 rapid antigen tests with self-collected vs health care worker–collected nasal and throat swab specimens

2023-12-06
About The Study: This randomized clinical trial found that a single health care worker-collected throat specimen had higher sensitivity for rapid antigen testing for SARS-CoV-2 than a nasal specimen. In contrast, the self-collected nasal specimens had higher sensitivity than throat specimens for symptomatic participants. Adding a throat specimen to the standard practice of collecting a single nasal specimen could improve sensitivity for rapid antigen testing in health care and home-based settings.  Authors: Tobias Todsen, M.D., Ph.D., of Copenhagen University Hospital in ...

First map of human limb development reveals unexpected growth processes and explains syndromes found at birth

First map of human limb development reveals unexpected growth processes and explains syndromes found at birth
2023-12-06
Human fingers and toes do not grow outward; instead, they form from within a larger foundational bud, as intervening cells recede to reveal the digits beneath. This is among many processes captured for the first time as scientists unveil a spatial cell atlas of the entire developing human limb, resolved in space and time. Researchers at the Wellcome Sanger Institute, Sun Yat-sen University, EMBL’s European Bioinformatics Institute and collaborators applied cutting-edge single-cell and spatial technologies to create an atlas characterising the cellular landscape of the early human limb, pinpointing the exact ...

Stanford Medicine-led study finds way to predict which of our organs will fail first

2023-12-06
Like any typical car or house or society, the pace at which parts of our bodies fall apart varies from part to part.  A study of 5,678 people, led by Stanford Medicine investigators, has shown that our organs age at different rates — and when an organ’s age is especially advanced in comparison with its counterpart in other people of the same age, the person carrying it is at heightened risk both for diseases associated with that organ and for dying. According to the study, about 1 in every 5 reasonably ...

Bowtie resonators that build themselves bridge the gap between nanoscopic and macroscopic

Bowtie resonators that build themselves bridge the gap between nanoscopic and macroscopic
2023-12-06
A central goal in quantum optics and photonics is to increase the strength of the interaction between light and matter to produce, e.g., better photodetectors or quantum light sources. The best way to do that is to use optical resonators that store light for a long time, making it interact more strongly with matter. If the resonator is also very small, such that light is squeezed into a tiny region of space, the interaction is enhanced even further. The ideal resonator would store light for a long time in a region at the size of a single atom. Physicists and engineers have struggled for decades with how ...

Embargoed press release: Blood hormone levels key to identifying which post-menopausal women will benefit most from taking anastrozole to prevent breast cancer 

2023-12-06
Research led by Queen Mary University of London’s Wolfson Institute of Population Health has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer.    Aromatase inhibitors such as anastrozole are recommended by the National Institute of Clinical Care and Excellence (NICE) as an option for preventive therapy in post-menopausal women at high risk of breast cancer. Anastrozole (Arimidex) is now also licensed by the ...

LAST 30 PRESS RELEASES:

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

[Press-News.org] New protein linked to early-onset dementia identified
Researchers have established a first potential therapeutic target for a type of early-onset dementia.